The BNIP3L Knockout SK-HEP-1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population designed for constitutive disruption of the BNIP3L gene in human SK-HEP-1 hepatic adenocarcinoma cells. This loss-of-function model serves as a powerful tool for investigating BNIP3L-mediated signaling networks without the limitations of transient knockdown approaches. The polyclonal nature of the product provides a representative heterogeneous knockout population suitable for pooled functional studies and drug screening campaigns where clonal variability is not the primary readout. This product is intended for use by experienced researchers in cell biology, molecular oncology, and hypoxia biology who require a robust and versatile model to dissect BNIP3L-dependent mechanisms.
SK-HEP-1 cells were originally derived from the ascites of a patient with adenocarcinoma of the liver and display both epithelial and endothelial-like characteristics, making them particularly valuable for studying tumor microenvironment interactions and metastatic biology. They are widely employed as a model for hepatocellular carcinoma (HCC) in vitro, offering a unique platform to examine liver cancer cell behavior under normoxic and hypoxic conditions. The cells retain key features of transformed hepatocytes, including active HIF-1 signaling and modulated apoptosis pathways, which are directly relevant to BNIP3L function. The background enables researchers to explore how BNIP3L deficiency alters the balance between cell death and survival in a clinically relevant context.
BNIP3L (also known as NIX) is a pro-apoptotic BCL2 family member that integrates hypoxia sensing with mitochondrial quality control and cell death. Under low oxygen tension, the transcription factor HIF1A transactivates BNIP3L, which is also regulated by upstream signals from TP53, FOXO3, and E2F1. The protein localizes to the outer mitochondrial membrane where it disrupts anti-apoptotic interactions with BCL2 and BCL2L1, facilitating mitochondrial outer membrane permeabilization and cytochrome c release. Simultaneously, BNIP3L recruits autophagy machinery through its LC3-interacting region (LIR), directly interacting with ATG8 family members such as MAP1LC3A and GABARAP as well as the mitochondrial fission factor MFF. This dual role orchestrates both intrinsic apoptosis and mitophagic clearance of damaged organelles, positioning BNIP3L as a critical node linking hypoxia response, autophagy, and programmed cell death.
In SK-HEP-1 cells, constitutive BNIP3L knockout enables precise dissection of hypoxia-induced mitophagy and apoptosis pathways in a liver cancer model that often exhibits aberrant cell death regulation. This system is particularly informative for studying how BNIP3L influences drug resistance, as HCC cells frequently rely on mitochondrial integrity to evade chemotherapeutic insults. The polyclonal knockout population allows researchers to assess overall phenotypic penetrance without clonal artifacts, while still supporting single-cell?Cderived subcloning if desired. By combining this model with hypoxia chambers or chemical HIF stabilizers, investigators can directly interrogate BNIP3L-dependent transcriptional programs and mitochondrial dynamics that contribute to hepatocellular carcinoma progression and therapeutic response.
Researchers can employ this product to investigate a wide range of BNIP3L-associated processes. Typical applications include monitoring mitophagy flux using Western blot for BNIP3L and LC3 (MAP1LC3B) lipidation in the presence and absence of chloroquine, quantifying apoptosis by Annexin V/propidium iodide flow cytometry alongside mitochondrial membrane potential dyes, and performing RT-qPCR for BNIP3L itself and HIF1A target genes. Immunofluorescence co-localization of LC3 with mitochondrial markers such as TOMM20 provides spatial confirmation of mitophagic events. The model is also suited for high-content screening of small-molecule modulators targeting the HIF1A?CBNIP3L axis and for evaluating how BNIP3L loss impacts BECN1- and ATG5-dependent autophagy pathways. For further technical inquiries and ordering information, please contact Ascent Research.
